Skip to main content
Veterinary Medicines

Hipraviar-SHS vakcina A.U.V.

Authorised
  • Turkey rhinotracheitis virus, strain 1062, Live

Product identification

Medicine name:
Hipraviar-SHS vakcina A.U.V.
Active substance:
  • Turkey rhinotracheitis virus, strain 1062, Live
Target species:
  • Chicken
  • Turkey
Route of administration:
  • In drinking water/milk use
  • Intraocular use
  • Nasal use
  • Nebulisation use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain 1062, Live
    2.50
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Oral lyophilisate
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Chicken
    • Turkey
      • Meat and offal
        0
        day
  • Intraocular use
    • Chicken
      • Meat and offal
        0
        day
    • Turkey
      • Meat and offal
        0
        day
  • Nasal use
    • Chicken
      • Meat and offal
        0
        day
    • Turkey
      • Meat and offal
        0
        day
  • Nebulisation use
    • Chicken
      • Meat and offal
        0
        day
    • Turkey
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD01
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."